Prophylactic Antibiotics Beneficial for Episiotomy, Second-Degree Tear
No significant effect seen on overall wound complications, but risk for clinically relevant wound complications significant reduced
Top FDA Drug Chief Resigns While Under Investigation
Dr. George Tidmarsh says he was targeted after questioning a new fast-track drug approval program
Blood Pressure Medication Recalled Over Cancer Risk
Recall due to the presence of nitrosamine impurities, classified as potential carcinogens
Reducing Use of Sleep Drugs Helps Older Adults Live Better
Benefits include reduction in falls and cognitive impairment and improvements in life expectancy, quality of life
Dupilumab Reduces Mucus Plug Scores With Moderate-to-Severe Asthma
Dupilumab treatment also improved patients’ lung function
Statins Not Tied to Cognitive Decline in Patients Receiving Doxorubicin
No worsening seen in cognitive function over 24 months among patients with lymphoma or breast cancer receiving doxorubicin
FDA to Ease Copycat Drug Rules, Speeding Access to Cheaper Drugs
Developers of biosimilars -- medicines that are near-identical copies of biologic drugs -- will no longer be required to conduct clinical trials to prove effectiveness
Cannabis Use Linked to Progression to Regular Tobacco Use
13.0 percent of total new regular tobacco use in the United States was attributed to cannabis use
Parental Opioid Rx More Than Doubles Risk for Persistent Use in Offspring
Associations not influenced by chronic musculoskeletal pain status in parents
FDA Approves Blenrep for Relapsed or Refractory Multiple Myeloma
Triplet combination treatment shows 51 percent reduction in the risk for death and tripled median progression-free survival versus a daratumumab-based triplet
